Evogene Ltd.EVGNNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank0
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P0
Near historical low
vs 5Y Ago
-5.6x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2024-21.29%
20233.34%
2022-9.79%
202117.04%
202013.51%
20193.77%
2018-5.98%
2017-8.73%
20169.93%
20152.15%